News Releases

Ultralife Corporation
Feb 08, 2018
Ultralife Corporation Reports Fourth Quarter Results

NEWARK, N.Y., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) reported operating income of $2.1 million on revenue of $22.5 million for the fourth quarter ended December 31, 2017 compared to operating income of $1.6 million on revenue of $21.6 million for the fourth quarter of 2016.  For total year 2017, Ultralife produced operating income of $6.5 million on revenue of $85.5 million compared to operating income of $3.8 million on revenue of $82.5 million for 2016.

“We ended a year of growth and accomplishments with our highest quarterly revenue, operating profit and EPS in five years.   Driven by a 32% increase in revenue from a broad range of government and defense customers, we delivered a 9.1% operating profit margin, up 150 basis points over last year’s fourth quarter, on total Company revenue growth of 4%,” said Michael D. Popielec, President and Chief Executive Officer.  “Throughout 2017, we aggressively pursued exciting new revenue contributions from market and sales reach expansion, new product development and customer partnerships, while preparing to launch new products to serve emerging IoT demand.  We achieved our stated goal of generating profitable growth for the year, increasing operating income by 72% on a 4% gain in revenue.  As a result of the actions taken in 2017 to lay the foundation for new revenue contributions in 2018, we are starting the year with a higher backlog than last year.  The combination of new revenue opportunities and continued disciplined execution of our business model places us in an excellent position to extend our track record of profitable growth.”

Fourth Quarter 2017 Financial Results

Revenue was $22.5 million, an increase of $.9 million, or 4%, compared to $21.6 million for the fourth quarter of 2016 reflecting higher government/defense sales for both business segments.  Battery & Energy Products sales decreased 5% to $16.8 million compared to $17.6 million last year due primarily to timing differences in medical sales which caused commercial sales to come in below last year, not fully offset by a 25% increase in government/defense sales.  Communications Systems sales grew 42% to $5.7 million compared to $4.0 million for the same period last year reflecting a 64% year-over-year increase in shipments of core products such as our 20-watt amplifiers, universal vehicle adaptors and power supplies, as well as a 25% increase in Vehicle Installed Power Enhanced Riflemen Appliqué (“VIPER”) revenues.

Gross profit was $6.9 million, or 30.5% of revenue, compared to $6.8 million, or 31.5% of revenue, for the same quarter a year ago.  Battery & Energy Products’ gross margin was 28.6% compared to 29.4% last year, and Communications Systems’ gross margin was 36.2% compared to 40.6% last year,  primarily due to sales mix.

Operating expenses were $4.8 million compared to $5.2 million last year reflecting continued tight control over discretionary spending.  Operating expenses were 21.4% of revenue compared to 23.9% of revenue for the year earlier period.

Operating income was $2.1 million compared to $1.6 million last year for an operating margin of 9.1% compared to 7.6% last year.

Net income was $3.8 million, which includes a one-time $1.9 million tax benefit, compared to net income of $1.7 million last year.  Reported earnings per share for the fourth quarter of 2017 of $0.24 include $0.12 from our operating performance compared to $0.11 per share for the fourth quarter of 2016, plus $0.12 related to the tax benefit.  Earnings per share for the full year of $0.49 include $0.37 per share from our 2017 operating performance compared to $0.23 for 2016.

Income tax net benefit was $1.7 million for the fourth quarter of 2017 compared to $0.1 million last year.  As a result of the Tax Cuts and Jobs Act, a one-time, non-cash tax benefit of $1.9 million was recognized in the fourth quarter of 2017 upon the revaluation, at the newly enacted 21% Federal tax rate, of deferred tax liabilities relating to book-to-tax differences on goodwill and other intangible assets.  There was no earnings impact for the revaluation of our domestic deferred tax assets, which include our net operating losses, as they continue to be fully reserved.

About Ultralife Corporation

Ultralife Corporation serves its markets with products and services ranging from power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe.

Headquartered in Newark, New York, the Company's business segments include Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit

Conference Call Information

Ultralife will hold its fourth quarter earnings conference call today at 10:00 AM ET. To participate in the live call, please dial (800) 915-4836 at least ten minutes before the scheduled start time, identify yourself and ask for the Ultralife call. A live webcast of the conference call will be available to investors in the Events & Presentations section of the Company's website at For those who cannot listen to the live broadcast, a replay of the webcast will be available shortly after the call at the same location.

This press release may contain forward-looking statements based on current expectations that involve a number of risks and uncertainties. The potential risks and uncertainties that could cause actual results to differ materially include: potential reductions in revenues from key customers, uncertain global economic conditions and acceptance of our new products on a global basis. The Company cautions investors not to place undue reliance on forward-looking statements, which reflect the Company's analysis only as of today's date. The Company undertakes no obligation to publicly update forward-looking statements to reflect subsequent events or circumstances.  Further information on these factors and other factors that could affect Ultralife’s financial results is included in Ultralife’s Securities and Exchange Commission (SEC) filings, including the latest Annual Report on Form 10-K.

(Dollars in Thousands)
  December 31,   December 31,
  2017   2016
Current Assets:      
Cash $ 18,330     $ 10,706  
Trade Accounts Receivable, Net   14,657       13,179  
Inventories   26,326       23,456  
Prepaid Expenses and Other Current Assets   2,603       2,079  
Total Current Assets   61,916       49,420  
Property, Equipment and Improvements, Net   7,570       7,999  
Goodwill, Intangibles and Other Assets   27,700       27,325  
Total Assets $ 97,186     $ 84,744  
Current Liabilities:              
Accounts Payable $ 8,787     $ 7,292  
Accrued Compensation and Related Benefits   2,413       1,258  
Accrued Expenses and Other Current Liabilities   3,039       2,778  
Total Current Liabilities   14,239       11,328  
Deferred Income Taxes and Other Non-Current Liabilities   3,898       5,556  
Total Liabilities   18,137       16,884  
Shareholders' Equity:      
Common Stock   1,966       1,932  
Capital in Excess of Par Value   180,211       178,163  
Accumulated Deficit   (82,894 )     (90,542 )
Accumulated Other Comprehensive Loss   (1,611 )     (3,080 )
Treasury Stock   (18,469 )     (18,443 )
Total Ultralife Equity   79,203       68,030  
Non-Controlling Interest   (154 )     (170 )
Total Shareholders’ Equity   79,049       67,860  
Total Liabilities and Shareholders' Equity $ 97,186     $ 84,744  

(In Thousands Except Per Share Amounts)
  Three Month Periods Ended   Year Ended
  December 31,   December 31,   December 31,   December 31,
  2017   2016   2017   2016
Battery & Energy Products $ 16,812     $ 17,611     $ 69,789     $ 64,753  
Communication Systems   5,697       4,014       15,742       17,707  
Total Revenues   22,509       21,625       85,531       82,460  
Cost of Products Sold:              
Battery & Energy Products   12,011       12,436       50,130       45,173  
Communication Systems   3,632       2,384       9,169       12,179  
Total Cost of Products Sold   15,643       14,820       59,299       57,352  
Gross Profit   6,866       6,805       26,232       25,108  
Operating Expenses:              
Research and Development   1,059       1,508       4,737       5,946  
Selling, General and Administrative   3,757       3,653       15,019        15,399   
Total Operating Expenses   4,816       5,161       19,756       21,345  
Operating Income   2,050       1,644       6,476       3,763  
Other Expense (Income)   (19 )     16       181       183  
Income Before Income Taxes   2,069       1,628       6,295       3,580   
Income Tax (Benefit) Provision    (1,739 )     (115 )     (1,369 )     98  
Net Income   3,808       1,743       7,664       3,482  
Net Income (Loss) Attributable to Non-Controlling Interest   8       (2     16       (27
Net Income Attributable to Ultralife Corporation $ 3,800     $ 1,745     $ 7,648     $ 3,509  
Other Comprehensive Income:              
Foreign Currency Translation Adjustments   716       (858 )     1,469       (2,173 )
Comprehensive Income Attributable to Ultralife $ 4,516     $ 887     $ 9,117     $ 1,336  
Net Income Per Share Attributable to Ultralife Common Shareholders – Basic $ .24     $ .11     $ .49     $ .23  
Net Income Per Share Attributable to Ultralife Common Shareholders – Diluted $ .24     $ .11     $ .48     $ .23  
Weighted Average Shares Outstanding – Basic   15,627       15,259       15,528       15,261  
Weighted Average Shares Outstanding – Diluted   16,031       15,360       15,858       15,405  

Company Contact:
Ultralife Corporation
Philip A. Fain
(315) 210-6110 

Investor Relations Contact:
Jody Burfening
(212) 838-3777 

Primary Logo

Source: Ultralife Corporation